Zytiga (Janssen Biotech, Inc.)
Welcome to the PulseAid listing for the Zytiga drug offered from Janssen Biotech, Inc.. This Cytochrome P450 17A1 Inhibitors [MoA],Cytochrome P450 17A1 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Janssen Biotech, Inc. |
| NON-PROPRIETARY NAME: | Abiraterone acetate |
| SUBSTANCE NAME: | ABIRATERONE ACETATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cytochrome P450 17A1 Inhibitors [MoA],Cytochrome P450 17A1 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-04-17 |
| END MARKETING DATE: | 0000-00-00 |
Zytiga HUMAN PRESCRIPTION DRUG Details:
| Item Description | Zytiga from Janssen Biotech, Inc. |
| LABELER NAME: | Janssen Biotech, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250(mg/1) |
| START MARKETING DATE: | 2017-04-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 57894-184_a7528969-71a7-4264-8424-f456ec43a8bb |
| PRODUCT NDC: | 57894-184 |
| APPLICATION NUMBER: | NDA202379 |
Other ABIRATERONE ACETATE Pharmaceutical Manufacturers / Labelers:
